Abstract
Neuropathic pain medications have dramatically changed the armamentarium of treatment options available to pain medicine practitioners. It is important to be familiar with the indications, dosing, and side effects associated with each of these medications.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- AEDs:
-
Anti-epileptic drugs
- AMPA:
-
2-(Aminomethyl)phenylacetic acid
- AV:
-
Atrioventricular block
- CBC:
-
Complete blood count
- GABA:
-
Gamma-aminobutyric acid
- HIV:
-
Human immunodeficiency virus
- HTN:
-
Hypertension
- IV:
-
Intravenous
- LV:
-
Liver
- MAOI:
-
Monamine oxidase inhibitor
- NMDA:
-
N-Methyl-d-aspartate
- PO BID:
-
Per os bis in die (Latin), twice a day
- PO TID:
-
Per os ter in die (Latin), three times a day
- TCAs:
-
Tricyclic antidepressant/s
References
Schestatsky P, Nascimento OJ. What do general neurologists needs to know about neuropathic pain? Arq Neuropsiquiatr. 2009;67(3A):741–9.
Vranken JH. Elucidation of pathophysiology and treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem. 2012;12(4):304–14.
Perucca E. An introduction to antiepileptic drugs. Epilepsia. 2005;46(4):31–7.
LaRoche S. A new look at the second-generation antiepileptic drugs: a decade of experience. Neurologist. 2007;13(3):133–9.
Luszczki JJ. Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics, interactions. Pharmacol Rep. 2009;61(2):197–216.
Gallop K. Review article: phenytoin use and efficacy in the ED. Emerg Med Australas. 2010;22(2):108–18.
Thorn CF, Whirl-Carrillo M, Leeder JS, Klein TE, Altman RB. PharmGKB summary: phenytoin pathway. Pharmacogenet Genomics. 2012;22(6):466–70.
Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol. 2006;61(3):246–55.
Aronson JK, Hardman M, Reynolds DJ. ABC of monitoring drug therapy. Phenytoin. Br Med J. 1992;305(6863):1215–8.
Von Winckelmann SL, Spriet I, Williams L. Therapeutic drug monitoring of phenytoin in critically ill patients. Pharmacotherapy. 2008;28(11):1391–400.
Scheinfeld N. Phenytoin in cutaneous medicine: its uses, mechanisms, and side effects. Dermatol Online J. 2003;9(3):6.
Craig S. Phenytoin poisoning. Neurocrit Care. 2005;3(2):161–70.
Al-Rubeaan K, Ryan EA. Phenytoin induced insulin insensitivity. Diabet Med. 2009;8(10):968–70.
Backonja MM. Use of anticonvulsants for treatments of neuropathic pain. Neurology. 2002;59(5):S14–7.
Schachter SC. Pharmacology of antiepileptic drugs; 2012. www.uptodate.com. Retrieved 10 Dec 2012.
Tremont-Lukats IW, Megeff C, Backonja MM. Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs. 2000;60(5):1029–52.
Krasowski MD. Therapeutic monitoring of the newer anti-epilepsy medication. Pharmaceuticals. 2010;3(6):1909–35.
Johannessen SI, Tomson T. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Clin Pharmacokinet. 2006;45(11):1061–75.
Riss J, Cloyd J, Gates J, Collins S. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008;118(2):69–86.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mathew, L., Kilcoyne, L. (2015). Neuropathic Anticonvulsant Medications. In: Sackheim, K. (eds) Pain Management and Palliative Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2462-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2462-2_13
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2461-5
Online ISBN: 978-1-4939-2462-2
eBook Packages: MedicineMedicine (R0)